Unit dosing of darbepoetin alfa for thetreatment of anemia in patients with end-stage renal disease being switched from recombinant human erythropoietin: Results of a phase IIIb, 27-week, multicenter, open-label study in Greek patients
达贝泊汀α单剂量治疗终末期肾病患者贫血(由重组人促红细胞生成素转换而来):一项在希腊患者中开展的IIIb期、27周、多中心、开放标签研究的结果
期刊:Current Therapeutic Research-Clinical and Experimental
影响因子:1.5
doi:10.1016/j.curtheres.2005.06.009
Bristoyiannis, Georgios; Germanos, Nikolaos; Grekas, Dimitrios; Hatzidimitriou, Christos; Iatrou, Christos; Memmos, Dimitrios; Moutafis, Spiros; Papachristoforou, Konstantinos; Papadoniou, Antonis; Pappas, Michalis; Sakellariou, George A; Siamopoulos, Kostas C; Sombolos, Konstantinos; Stamatelou, Kiriaki; Stathakis, Charalambos P; Stavgiannoudakis, Georgios; Stratigis, Spiros; Syrganis, Christos; Tsakiris, Dimitris; Valis, Dimitris; Vlahojannis, Jannis G; Vlassopoulos, Dimosthenis